These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12450439)

  • 1. Technosphere/Insulin--a new approach for effective delivery of human insulin via the pulmonary route.
    Pfützner A; Mann AE; Steiner SS
    Diabetes Technol Ther; 2002; 4(5):589-94. PubMed ID: 12450439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technosphere/Insulin--proof of concept study with a new insulin formulation for pulmonary delivery.
    Steiner S; Pfützner A; Wilson BR; Harzer O; Heinemann L; Rave K
    Exp Clin Endocrinol Diabetes; 2002 Jan; 110(1):17-21. PubMed ID: 11835120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary insulin delivery by means of the Technosphere drug carrier mechanism.
    Pfützner A; Forst T
    Expert Opin Drug Deliv; 2005 Nov; 2(6):1097-106. PubMed ID: 16296812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technosphere insulin technology.
    Richardson PC; Boss AH
    Diabetes Technol Ther; 2007 Jun; 9 Suppl 1():S65-72. PubMed ID: 17563306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of inhaled technosphere insulin.
    Neumiller JJ; Campbell RK; Wood LD
    Ann Pharmacother; 2010; 44(7-8):1231-9. PubMed ID: 20516362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled insulin--does it become reality?
    Siekmeier R; Scheuch G
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():81-113. PubMed ID: 19218634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of pharmacokinetic and pharmacodynamic properties of single-dose oral insulin spray and subcutaneous insulin injection in healthy subjects using the euglycemic clamp technique.
    Cernea S; Kidron M; Wohlgelernter J; Modi P; Raz I
    Clin Ther; 2004 Dec; 26(12):2084-91. PubMed ID: 15823772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled micronized crystalline human insulin using a dry powder inhaler: dose-response and time-action profiles.
    Rave K; Nosek L; Heinemann L; Gonzales C; Ernest CS; Chien J; Muchmore D
    Diabet Med; 2004 Jul; 21(7):763-8. PubMed ID: 15209771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technosphere insulin: an inhaled prandial insulin product.
    Neumiller JJ; Campbell RK
    BioDrugs; 2010 Jun; 24(3):165-72. PubMed ID: 20462282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New ways of insulin delivery.
    Heinemann L
    Int J Clin Pract Suppl; 2011 Feb; (170):31-46. PubMed ID: 21323811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and linear exposure of AFRESA compared with the subcutaneous injection of regular human insulin.
    Rave K; Potocka E; Heinemann L; Heise T; Boss AH; Marino M; Costello D; Chen R
    Diabetes Obes Metab; 2009 Jul; 11(7):715-20. PubMed ID: 19476477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled technosphere insulin: a novel delivery system and formulation for the treatment of types 1 and 2 diabetes mellitus.
    Kugler AJ; Fabbio KL; Pham DQ; Nadeau DA
    Pharmacotherapy; 2015 Mar; 35(3):298-314. PubMed ID: 25809179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary function over 2 years in diabetic patients treated with prandial inhaled Technosphere Insulin or usual antidiabetes treatment: a randomized trial.
    Raskin P; Heller S; Honka M; Chang PC; Boss AH; Richardson PC; Amin N
    Diabetes Obes Metab; 2012 Feb; 14(2):163-73. PubMed ID: 21951325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intradermal microneedle delivery of insulin lispro achieves faster insulin absorption and insulin action than subcutaneous injection.
    Pettis RJ; Ginsberg B; Hirsch L; Sutter D; Keith S; McVey E; Harvey NG; Hompesch M; Nosek L; Kapitza C; Heinemann L
    Diabetes Technol Ther; 2011 Apr; 13(4):435-42. PubMed ID: 21355718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Population Dose-Response Model for Inhaled Technosphere Insulin Administered to Healthy Subjects.
    Rüppel D; Dahmen R; Boss A; Jäger R; Grant M; Baughman R; Klabunde T
    CPT Pharmacometrics Syst Pharmacol; 2017 Jun; 6(6):365-372. PubMed ID: 28568813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-response relationships of inhaled insulin delivered via the Aerodose insulin inhaler and subcutaneously injected insulin in patients with type 2 diabetes.
    Kim D; Mudaliar S; Chinnapongse S; Chu N; Boies SM; Davis T; Perera AD; Fishman RS; Shapiro DA; Henry R
    Diabetes Care; 2003 Oct; 26(10):2842-7. PubMed ID: 14514589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PROMAXX inhaled insulin: safe and efficacious administration with a commercially available dry powder inhaler.
    Heise T; Brugger A; Cook C; Eckers U; Hutchcraft A; Nosek L; Rave K; Troeger J; Valaitis P; White S; Heinemann L
    Diabetes Obes Metab; 2009 May; 11(5):455-9. PubMed ID: 19236443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technosphere insulin: inhaled prandial insulin.
    Setji TL; Hong BD; Feinglos MN
    Expert Opin Biol Ther; 2016; 16(1):111-7. PubMed ID: 26567896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin pharmacokinetics following dosing with Technosphere insulin in subjects with chronic obstructive pulmonary disease.
    Potocka E; Amin N; Cassidy J; Schwartz SL; Gray M; Richardson PC; Baughman RA
    Curr Med Res Opin; 2010 Oct; 26(10):2347-53. PubMed ID: 20804443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technosphere inhaled insulin (Afrezza).
    Rendell M
    Drugs Today (Barc); 2014 Dec; 50(12):813-27. PubMed ID: 25588086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.